Argos Therapeutics, Inc. Debt to Equity Ratio 2014-2018 | ARGSQ
Current and historical debt to equity ratio values for Argos Therapeutics, Inc. (ARGSQ) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Argos Therapeutics, Inc. debt/equity for the three months ending September 30, 2018 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2018-09-30 |
$0.02B |
$-0.01B |
-1.87 |
2018-06-30 |
$0.03B |
$-0.01B |
-3.06 |
2018-03-31 |
$0.03B |
$-0.00B |
-7.97 |
2017-12-31 |
$0.03B |
$-0.01B |
-3.25 |
2017-09-30 |
$0.04B |
$-0.02B |
-2.52 |
2017-06-30 |
$0.05B |
$-0.02B |
-2.26 |
2017-03-31 |
$0.04B |
$-0.01B |
-3.17 |
2016-12-31 |
$0.09B |
$0.01B |
14.76 |
2016-09-30 |
$0.09B |
$0.02B |
4.40 |
2016-06-30 |
$0.06B |
$0.00B |
14.59 |
2016-03-31 |
$0.06B |
$-0.02B |
-3.12 |
2015-12-31 |
$0.06B |
$-0.03B |
-2.10 |
2015-09-30 |
$0.06B |
$-0.01B |
-4.18 |
2015-06-30 |
$0.04B |
$0.01B |
9.35 |
2015-03-31 |
$0.04B |
$0.02B |
2.58 |
2014-12-31 |
$0.03B |
$0.03B |
1.05 |
2014-09-30 |
$0.03B |
$0.05B |
0.65 |
2014-06-30 |
$0.01B |
$0.06B |
0.23 |
2014-03-31 |
$0.02B |
$0.07B |
0.20 |
2013-12-31 |
$0.01B |
$0.04B |
0.35 |
2013-09-30 |
$0.00B |
|
0.00 |
2013-06-30 |
$0.00B |
|
0.00 |
2013-03-31 |
$0.00B |
|
0.00 |